Growth Metrics

Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2016 - 2025)

Jazz Pharmaceuticals has reported Prepaid Assets over the past 16 years, most recently at $324.0 million for Q4 2025.

  • Quarterly Prepaid Assets rose 82.6% to $324.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $324.0 million through Dec 2025, up 82.6% year-over-year, with the annual reading at $324.0 million for FY2025, 82.6% up from the prior year.
  • Prepaid Assets was $324.0 million for Q4 2025 at Jazz Pharmaceuticals, up from $146.9 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $354.2 million in Q3 2024 and troughed at $91.9 million in Q4 2022.
  • The 5-year median for Prepaid Assets is $163.8 million (2024), against an average of $196.4 million.
  • Biggest five-year swings in Prepaid Assets: surged 286.07% in 2021 and later crashed 58.53% in 2025.
  • Tracing JAZZ's Prepaid Assets over 5 years: stood at $131.4 million in 2021, then plummeted by 30.06% to $91.9 million in 2022, then soared by 249.04% to $320.8 million in 2023, then tumbled by 44.7% to $177.4 million in 2024, then surged by 82.6% to $324.0 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $324.0 million, $146.9 million, and $297.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.